These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. On the different response of Salmonella typhimurium hisG46 and TA1530 to mutagenic action of base analogues. Janion C Acta Biochim Pol; 1979; 26(1-2):171-7. PubMed ID: 388954 [TBL] [Abstract][Full Text] [Related]
83. The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N Bluemling GR; Mao S; Natchus MG; Painter W; Mulangu S; Lockwood M; De La Rosa A; Brasel T; Comer JE; Freiberg AN; Kolykhalov AA; Painter GR Antiviral Res; 2023 Jan; 209():105453. PubMed ID: 36379378 [TBL] [Abstract][Full Text] [Related]
84. Identification of critical host mitochondrion-associated genes during Ehrlichia chaffeensis infections. Von Ohlen T; Luce-Fedrow A; Ortega MT; Ganta RR; Chapes SK Infect Immun; 2012 Oct; 80(10):3576-86. PubMed ID: 22851751 [TBL] [Abstract][Full Text] [Related]
85. Molnupiravir inhibits human norovirus and rotavirus replication in 3D human intestinal enteroids. Santos-Ferreira N; Van Dycke J; Chiu W; Neyts J; Matthijnssens J; Rocha-Pereira J Antiviral Res; 2024 Mar; 223():105839. PubMed ID: 38373532 [TBL] [Abstract][Full Text] [Related]
87. [Molecular mechanism of N4-aminocytidine mutagenesis]. Negishi K Yakugaku Zasshi; 1990 May; 110(5):293-303. PubMed ID: 2198343 [TBL] [Abstract][Full Text] [Related]
88. Phosphorylation of uridine and cytidine by uridine-cytidine kinase. Qian Y; Ding Q; Li Y; Zou Z; Yan B; Ou L J Biotechnol; 2014 Oct; 188():81-7. PubMed ID: 25160914 [TBL] [Abstract][Full Text] [Related]
89. Structure of human uridine-cytidine kinase 2 determined by SIRAS using a rotating-anode X-ray generator and a single samarium derivative. Appleby TC; Larson G; Cheney IW; Walker H; Wu JZ; Zhong W; Hong Z; Yao N Acta Crystallogr D Biol Crystallogr; 2005 Mar; 61(Pt 3):278-84. PubMed ID: 15735337 [TBL] [Abstract][Full Text] [Related]
90. Mutagenicity of N4-aminocytidine and its derivatives in Chinese hamster lung V79 cells. Incorporation of N4-aminocytosine into cellular DNA. Nomura A; Negishi K; Hayatsu H; Kuroda Y Mutat Res; 1987 Apr; 177(2):283-7. PubMed ID: 3561428 [TBL] [Abstract][Full Text] [Related]
92. Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance. Strizki JM; Gaspar JM; Howe JA; Hutchins B; Mohri H; Nair MS; Kinek KC; McKenna P; Goh SL; Murgolo N Antimicrob Agents Chemother; 2024 Jan; 68(1):e0095323. PubMed ID: 38047645 [TBL] [Abstract][Full Text] [Related]
93. Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2. Painter WP; Holman W; Bush JA; Almazedi F; Malik H; Eraut NCJE; Morin MJ; Szewczyk LJ; Painter GR Antimicrob Agents Chemother; 2021 May; 65(5):. PubMed ID: 33649113 [TBL] [Abstract][Full Text] [Related]
94. New insights into the pyrimidine salvage pathway of Saccharomyces cerevisiae: requirement of six genes for cytidine metabolism. Kurtz JE; Exinger F; Erbs P; Jund R Curr Genet; 1999 Sep; 36(3):130-6. PubMed ID: 10501935 [TBL] [Abstract][Full Text] [Related]